Oral Kaposi's sarcoma: A review and update

International Journal of Dermatology

Volumn 52, Issue 6, 2013, Pages 666-672

  Fatahzadeh, Mahnaz ^a   Schwartz, Robert A ^b  

^a RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; ANTHRACYCLINE; BLEOMYCIN; CYCLOSPORIN; ETOPOSIDE; FOSCARNET; GANCICLOVIR; LIQUID NITROGEN; MATRIX METALLOPROTEINASE INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PACLITAXEL; RAPAMYCIN; TACROLIMUS; TETRADECYL SULFATE SODIUM; THALIDOMIDE; VASCULOTROPIN INHIBITOR; VINBLASTINE; VINCRISTINE;

ACUTE GRAFT REJECTION; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CRYOTHERAPY; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; EPIDEMIC; EXTERNAL BEAM RADIOTHERAPY; GRAFT RECIPIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; KAPOSI SARCOMA; LOCAL THERAPY; MOUTH INFECTION; MOUTH LESION; MOUTH TUMOR; MULTIMODALITY CANCER THERAPY; OPPORTUNISTIC INFECTION; ORAL MUCOSITIS; ORGAN TRANSPLANTATION; PALLIATIVE THERAPY; PHOTODYNAMIC THERAPY; REVIEW; SCLEROTHERAPY; SYSTEMIC THERAPY; TASTE DISORDER; TISSUE NECROSIS; TUMOR LOCALIZATION; ULCER;

ANTINEOPLASTIC AGENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MOUTH NEOPLASMS; NEOPLASM STAGING; SARCOMA, KAPOSI;

EID: 84878140863     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2012.05758.x     Document Type: Review

References (48)

1. Kaposi M. Idiopathisches multiples Pigmensarkom der Haut. Arch Dermatol Syph 1872; 4: 265-273.
2. Feller L, Khammissa R, Gugushe T, et al. HIV-associated Kaposi sarcoma in African children. SADJ 2010; 65: 20-22.
3. Feller L, Lemmer J. Oral Kaposi sarcoma. Pantonowitz L, Stebbing J, Dezube BJ, eds. Kaposi Sarcoma: a Model of Oncogenesis. Kerala: Research Signpost, 2010: 295-303.
4. Patrikidou A, Vahtsevanos K, Charalambidou M, et al. Kaposi's sarcoma in the head and neck area. Head Neck 2009; 31: 260-268.
5. Feit H. Sarcoma (Kaposi). Arch Derm Syphilol 1928; 18: 611-612.
6. Marcelin AG, Calvez V, Dussaix E. KSHV after an organ transplant: should we screen? Curr Top Microbiol Immunol 2007; 312: 245-262.
7. Farge D, Lebbe C, Marjanovic Z, et al. Human herpesvirus 8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Group Cooperatif de Transplantation d'lle de France (GCIF). Transplantation 1999; 67: 1236-1242.
8. Penn I. Sarcomas in organ allograft recipients. Transplantation 1995; 60: 1485-1491.
9. Wamburu G, Masenga EJ, Moshi EZ, et al. HIV associated and non-HIV associated types of Kaposi's sarcoma in an African population in Tanzania. Status of immune suppression and HHV-8 seroprevalence. Eur J Dermatol 2006; 16: 677-682.
10. Mwakidonja AR, Pak F, Pyakurel P, et al. Oral Kaposi's sarcoma in Tanzania: presentation, immunopathology and human herpesvirus 8 association. Oncol Rep 2007; 17: 1291-1299.
11. Feller L, Jadwat Y, Raubenheimer EJ. Kaposi sarcoma and calcium channel blocker-induced gingival enlargement occurring simultaneously: review of the literature and report of a case. Oral Biosci Med 2004; 4: 291-297.
12. Larger I, Altini M, Coleman H, Ali H. Oral Kaposi's sarcoma: a clinicopathologic study from South Africa. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 96: 701-710.
13. Ficcara G, Berson AM, Silverman SJ, et al. Kaposi's sarcoma of the oral cavity: a study of 134 patients with a review of the pathogenesis, epidemiology, clinical aspects and treatment. Oral Surg Oral Med Oral Pathol 1988; 66: 543-550.
14. Rohrmus B, Thoma-Gerber E, Bogner J, Rocken M. Outlook in oral and cutaneous Kaposi's sarcoma. Lancet 2000; 356: 2160.
15. Feller L, Masipa J, Wood N, et al. The prognostic significance of facial lymphoedema in HIV-seropositive subjects with Kaposi sarcoma. AIDS Res Ther 2008; 5: 1-6.
16. McCormick SU. Intralesional vinblastine injections for the treatment of oral Kaposi's sarcoma: report of 10 patients with 2-year follow-up. Oral Maxillofac Surg 1996; 54: 583-587.
17. Kalpidis CD, Lysitsa SN, Lombardi T, et al. Gingival involvement in a case series of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma. J Periodontol 2006; 77: 523-533.
18. Petit JC, Ripamonti U, Hille J. Progressive changes of Kaposi's sarcoma of the gingiva and palate. Case report in an AIDS patient. J Periodontol 1986; 57: 159-163.
19. Lausten LL, Ferguson BL, Barker BF, Cobb CM. Oral Kaposi sarcoma associated with severe alveolar bone loss: case report and review of the literature. J Periodontol 2003; 74: 1668-1675.
20. Nichols CM, Flaitz CM, Hicks MJ. Primary intraosseous Kaposi's sarcoma of the maxilla in human immunodeficiency virus infection. Review of literature and report of case. J Oral Maxillofac Surg 1995; 53: 325-329.
21. Regezi JA, MacPhail LA, Daniels TE, et al. Oral Kaposi's sarcoma: a 10-year retrospective histopathologic study. J Oral Pathol Med 1993; 22: 292-297.
22. Daly CG, Allan BP, Bhagwandeen SB, Sutherland DC. Kaposi's sarcoma of the palate in a patient with AIDS: an unusual presentation. Aust Dent J 1989; 34: 101-105.
23. Scully C, Langdon J, Evans J. Marathon of eponyms: II. Kaposi sarcoma. Oral Dis 2010; 16: 402-403.
24. Lopez de Blanc S, Sambuelli R, Femopase F, et al. Bacillary angiomatosis affecting the oral cavity Report of two cases and review. J Oral Pathol Med 2000; 29: 91.
25. Seymour RA, Smith DG, Rogers SR. Comparative effect of azathioprine and cyclosporine on some gingival health parameters of renal transplant patients. A longitudinal study. J Clin Periodontol 1987; 14: 610-613.
26. Ramirez-Amador V, Anaya-Saavedra G, Martinez-Mata G. Kaposi's sarcoma of the head and neck: a review. Oral Oncol 2010; 46: 135-145.
27. Mendez JC, Paya CV. Kaposi's sarcoma in transplantation. Herpes 2000; 71: 18-23.
28. Vanni T, Sprinz E, Machado MW, et al. Systemic treatment of AIDS-related Kaposi sarcoma: current status and perspectives. Cancer Treat Rev 2006; 32: 445-455.
29. Bottler T, Kuttenberger J, Hardt N, et al. Non-HIV-associated Kaposi's sarcoma of the tongue. Case report and review of the literature. Int J Oral Maxillofac Surg 2007; 36: 1218.
30. Lebbe C, Legendre C, Frances C. Kaposi sarcoma in transplantation. Transplant Rev (Orlando) 2008; 22: 252-261.
31. Jakob L, Metzler G, Chen K-M, Garbe C. Non-AIDS associated Kaposi's sarcoma: clinical features and treatment outcome. PLoS One 2011; 6: 18397.
32. Paghdal KV, Schwartz RA. Sirolimus (rapamycin): from the soil of Easter Island to a bright future. J Am Acad Dermatol 2007; 57: 1046-1050.
33. Nicolas LA, Adang LA, Kedes DH. Rapamycin blocks production of KSHV/HHV-8: insights into the anti-tumor activity of an immunosuppressant drug. PLoS One 2011; 6: 14535.
34. Serraino D, Piselli P, Scuderi M, et al.; Studio Italiano Trapianti e Infezioni. Screening for human herpesvirus 8 antibodies in Italian transplantation centers. Clin Infect Dis 2005; 40: 203-205.
35. Nasti G, Mortellota F, Berreta M, et al. Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma. Cancer 2003; 98: 2440-2446.
36. Mortellotta F, Berretta M, Vaccher E, et al. AIDS-related Kaposi's sarcoma: state of the art and therapeutic strategies. Curr HIV Res 2009; 7: 634-638.
37. Feller L, Anagnostopoulos C, Wood N, et al. Human immunodeficiency virus-associated Kaposi sarcoma as an immune reconstitution inflammatory syndrome: a literature review and case report. J Periodontol 2008; 79: 362-368.
38. Lynen L, Zolfo M, Huyst V, et al. Management of Kaposi's sarcoma in resource-limited settings in the era of HAART. AIDS Rev 2005; 7: 13-21.
39. Brambilla L, Bellinvia M, Tourlaki A, et al. Intralesional vincristine as first-line therapy for nodular lesions in classic Kaposi sarcoma: a prospective study in 151 patients. Br J Dermatol 2010; 162: 854-859.
40. Ramírez-Amador V, Esquivel-Pedraza L, Lozada-Nur F, et al. Intralesional vinblastine vs. 3% sodium tetradecyl sulfate for the treatment of oral Kaposi's sarcoma. A double-blind, randomized clinical trial. Oral Oncol 2002; 38: 460-467.
41. Lucatorto FM, Sapp JP. Treatment of oral Kaposi's sarcoma with a sclerosing agent in AIDS patients. A preliminary study. Oral Surg Oral Med Oral Pathol 1993; 75: 192-198.
42. Sulis E, Floris S, Sulis ML, et al. Interferon-alpha administered intralesionally in skin and oral lesions in heterosexual drug-addicted patients with AIDS-related Kaposi's sarcoma. Eur J Cancer Clin Oncol 1989; 25: 759-761.
43. Tappero J, Berger T, Kaplan L, et al. Cryotherapy for cutaneous Kaposi's sarcoma (KS) associated with acquired immune deficiency syndrome (AIDS): a Phase II trial. J Acquir Immune Defic Syndr 1991; 4: 839-846.
44. Housri N, Yarchoan R, Kaushal A. Radiotherapy for patients with the human immunodeficiency virus: are special precautions necessary? Cancer 2010; 116: 273-283.
45. Caccialanza M, Piccinno R, Gnecchi L, et al. Intracavitary contact X-ray therapy of oral HIV-associated Kaposi's sarcoma. Int J STD AIDS 1997; 8: 581-584.
46. Krown S, Metroka C, Wrenz J; AIDS Clinical Trials Group Oncology Committee. Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response and staging criteria. J Clin Oncol 1989; 7: 1201-1207.
47. Dezube BJ, Pantanowitz L, Aboulafia DM. Management of AIDS-related Kaposi sarcoma: advances in target discovery and treatment. AIDS Read 2004; 14: 236-253.
48. Kim E, Ko HH, Yoshida EM. Treatment issues surrounding hepatitis C in renal transplantation: a review. Ann Hepatol 2011; 10: 5-14.